JR-141-BR21

· JCR Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JR-141-BR21, covering 2025-07-24 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II [Phase 2]